淡投2015-03-20 00:49
AACR abstract title suggests signal of activity in solid tumors, specifically mesothelin expressing cancers $ Juno Therapeutics (JUNO)$ $Kite Pharma(KITE)$ $Bellicum Pharmaceuticals (BLCM)$查看全文
againstodds2015-03-09 15:30
$Bellicum Pharmaceuticals (BLCM)$ 请教下 Bellicum的 switch可以控制其他第三方的 CAR-T cell 还是只能应用在自家的 T cell 上?@疑夕 @股市之猪老白ISIG查看全文
王伟CFA美股MCORLEO2015-03-06 00:17
回复@Tothenorth: 谢谢 目前为止就推荐了两个生物医药股$Second Sight Medical Products(EYES)$ $ Juno Therapeutics (JUNO)$ ,还有$Bellicum Pharmaceuticals (BLCM)$ 是跟juno一起的。药股研究起来比较耗精力,实在没时间。大家可以关注@股市之猪老白ISIG ,还有@我是_一级棒 他们研究比较多。/...查看全文
$Bellicum制药(BLCM)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-23-120984 Act: 34 Size: 219 KB 网页链接
$Bellicum制药(BLCM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-056578 Size: 22 KB 网页链接
$Bellicum制药(BLCM)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001628280-23-039830 Act: 34 Size: 808 KB 网页链接
$Bellicum制药(BLCM)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001628280-23-038953 Act: 34 Size: 4 MB 网页链接
$Bellicum制药(BLCM)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001628280-23-033257 Act: 34 Size: 199 KB 网页链接
$Bellicum制药(BLCM)$ 8-K Current report, item 7.01 Accession Number: 0001628280-23-030016 Act: 34 Size: 186 KB 网页链接
$Bellicum制药(BLCM)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001628280-23-028893 Act: 34 Size: 4 MB 网页链接
$Bellicum制药(BLCM)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-23-000485 Act: 34 Size: 3 KB 网页链接
$Bellicum制药(BLCM)$ 8-K Current report, item 5.02 Accession Number: 0001628280-23-020619 Act: 34 Size: 197 KB 网页链接
$Bellicum制药(BLCM)$ 8-K Current report, item 3.01 Accession Number: 0001628280-23-020109 Act: 34 Size: 198 KB 网页链接